What is Patent Thinking?
Patent Thinking is a new design methodology which combines Patent Design and Design Thinking. Using this new ideation methodology teams, startups, academia and enterprises can develop new ideas, products and processes by prototyping a lean patent application. The applied method could take the form of an individual work or a group activity.Patent thinking includes principles from technology, product management, product design, business and intellectual property.Patents are considered to be one of the most classic and well known forms of clearly depicting and protecting an innovative product/service or invention by a sole inventor or a group of inventors. #patents have clear rules and structure. They have high value due to the large effort, thought and resources inventors put in to get (...)
FSF statement on Microsoft joining the Open Invention Network — Free Software Foundation — working together for free software
Microsoft’s announcements on October 4th and 10th, that it has joined both LOT and the Open Invention Network (OIN), are significant steps in the right direction, potentially providing respite from Microsoft’s well-known extortion of billions of dollars from free software redistributors.
These steps, though, do not by themselves fully address the problem of computational idea patents, or even Microsoft’s specific infringement claims.
Vigilante engineer stops Waymo from patenting key lidar technology
Eric Swildens had no dog in the fight other than intellectual curiosity. Article word count: 1218
Article intro image
A lone engineer has succeeded in doing what Uberʼs top lawyers and expert witnesses could not—overturning most of a foundational patent covering arch-rival Waymoʼs lidar laser ranging devices.
Following a surprise left-field complaint by Eric Swildens, the US Patent and Trademark Office (USPTO) has rejected all but three of 56 (...)
Community IP: the case for an ICO Patent fund
In 2014 I applied for a patent on the particular type of hardware wallet i was developing at the time. I thought it was a good idea, once before someone else had patented something I had publicly disclosed and thought it a necessary to protect myself going forward. Long story short- I abandoned the patent process after vehement protest from some members in the then Bitcoin community. (Interestingly, I paid my lawyer in Bitcoin- perhaps one of the first transactions of it’s kind: BitcoinTalk). At the time I had been convinced the precedent was a bad one to follow, but I’ve never stopped thinking about how the ‘real’ world intersects with #blockchain- and how blockchain is increasingly become the ‘real’ world.It is inevitable that elements of blockchain will be patented, it’s already happening. (...)
▻https://goo.gl/Tb9zB8*Black Panther spoilers ahead*Now I’m not much of a moviegoer, but boy did I enjoy Black Panther! I especially loved the twist in the second half where T’challa rules Wakanda with the belief he the uncontested heir, only to be ousted by long-lost cousin Erik Killmonger. A similar saga seems to be taking place in US courts where #blackberry has claimed that a number of Facebook’s messaging features have been infringing Blackberry’s #patents. Be it in Black Panther, or BlackBerry, one common question sprang into my head: “Why did they wait so long?!”Blackberry’s 117-page complaint in the California District Court, alleging that Facebook and its subsidiaries, Whatsapp and Instagram, have been infringing seven of Blackberry’s patents. BlackBerry claimed that these patents were (...)
How UCLA Is Fighting Proxy #Patent Battle for Expensive #Cancer Drug in #India - The Wire
UCLA appears to be representing the pharmaceutical companies Pfizer, Medivation and Astellas in its battle. They aren’t telling the Delhi high court this, but they do talk about it in other documents.
Kaspersky Lab turns the tables, forces “patent troll” to pay cash to end case | Ars Technica
“Why don’t you pay us $10,000 ?”
Les pourris d’#Elsevier continuent dans leur appropriation de la recherche scientifique avec, cette fois, du #patentMadness. Elsevier a breveté le #peer_review (et l’Office des Brevets, vendu aux industriels de la #propriété_intellectuelle, a accepté).
Mobilisation for start of mass opposition against patent on tomatoes
European-wide coalition increases pressure on politicians and the European #Patent Office
12 April 2016 / This week, a European-wide coalition is starting a mass opposition against a patent held by the Swiss company Syngenta on tomatoes produced by conventional breeding. We will be mobilising thousands of people within the time period of the opposition lasting until 12 May. The organisations taking part in this action will also be raising the pressure on European politicians to take measures against patents on plants and animals.
No patent if invention lies only in computer programme, says Indian Patent Office - Business Standard
The Indian Patent Office has come out with a new guideline for its officials to follow when deciding on applications related to software and hardware related inventions (...) if the contribution lies only in mathematical method, business method or algorithm, deny the claim.
Ex-hedge funder buys rights to AIDS drug and raises price from $13.50 to $750 per pill
Apparemment, c’est une pratique en vogue dans le secteur.
Voir cette article qui parle aussi du #Daraprim et d’autres molécules soumises à augmentation spéculative. ▻http://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html?_r=0
Turing’s price increase is not an isolated example. Although most of the attention on pharmaceutical prices has been on new drugs for diseases like cancer, hepatitis C and high cholesterol, there is also growing concern about huge price increases on older drugs, some of them generic, that have long been mainstays of treatment.
Although some price increases have been caused by shortages, others have resulted from a business strategy of buying old neglected drugs and turning them into high-priced “specialty drugs.”
Martin Shkreli, le #prédateur des maladies orphelines est sous le coup d’une enquête concernant son passage chez Retrophin (▻http://www.bloomberg.com/bw/articles/2014-04-17/retrophins-martin-shkreli-the-biotech-short-seller-who-went-long) de la part de ses anciens collaborateurs(▻http://www.sec.gov/Archives/edgar/data/1438533/000119312515292581/d19898dex991.htm).
A Biotech Company Escalates the War Against Its Own Founder
Celui-ci est particulièrement gratiné mais c’est un peu l’arbre qui cache la forêt : comme dit @supergeante, c’est très courant dans tout le secteur, où l’on met le profit avant la vie, avec des conséquences tragiques pour des millions de personnes. L’indignation morale doit devenir politique.
Where there is oil and gas there is Schlumberger | Environment | The Guardian
One of Schlumberger’s tricks of the trade is its near-statelessness. Unlike Halliburton, it is not US-owned. Despite being a publicly listed company both in the US and the UK, and having “headquarters” in London (a sleek glass skyscraper just yards from Buckingham Palace), Paris, The Hague and Houston, Schlumberger is formally incorporated in Curaçao, a Caribbean offshore haven with ties to the Netherlands.http://interactive.guim.co.uk/uploader/embed/2015/05/schlumberger_map-zip/giv-21277xnX5J1J8yVGA/img/Schlumberger_Map-2-0-0.png
(...) “You could almost say Schlumberger is the Apple of the oil fields, the high tech company, they’re ubiquitous,” explains Robert MacKenzie, an analyst at Iberia Capital Partners and a former employee of Schlumberger.
“If you’re trying to develop a field and you want the best you hire Schlumberger. If you’re not certain how to work it and you want someone to help figure out how you develop it you call Schlumberger. They have driven many technology advances in the industry in the past and they continue to do that.”
Schlumberger’s technological dominance is reflected in its formidable #patent portfolio.
Global intellectual property filings see boost in 2013 – UN report
The 2014 edition of the World Intellectual Property Indicators – a benchmark report gleaning data from 100 countries and released by the UN’s World Intellectual Property Organization (WIPO) – noted that applications for trademarks, industrial designs and utility models increased over the last year, fuelled by strong demand in China, the United States and Japan.
(…) Plant varieties, (…), reached “a new record,” according to WIPO, with around 15,200 filings worldwide – a 4.7 per cent increase in growth from the previous year.
Fight #Ebola Now, Solve #Patent Issues Later
GOP cuts funding request to fight Ebola | TheHill
House Republicans indicated Tuesday that they will provide less than half of the White House’s funding request to fight Ebola in the next government spending bill.
According to a source familiar with the negotiations, House Appropriations Committee Chairman Hal Rogers (R-Ky.) agreed as of Tuesday morning to spend a total of $40 million to fight the epidemic in the 2015 spending bill.
(les deux liens via @james_love)
#Eli_Lilly Raises Stakes: Says Canada Now Owes It $500 Million For Not Granting A #Patent It Wanted
A few months ago we wrote about the extraordinary — and worrying — case of Eli Lilly suing Canada after the latter had refused to grant a pharma patent. Eli Lilly’s contention was that by failing to grant its patent (even if it didn’t meet the criteria for a patent in Canada), Canada had “expropriated” Eli Lilly’s property — and that it should be paid $100 million as “compensation”.
But it seems that the company has had second thoughts. Not that its action was outrageous, and that it ought quietly to retract its suit in the hope that people might just forget about this display of presumption; instead, it has decided it was far too generous in asking for only $100 million, as this Globe and Mail story explains:
La guerre des #brevets | ARTE mardi 01 juillet (81 min)
Rediffusion lundi 07.07 à 3h10
Arte+7 : 01.07-08.07.2014
Comment le système des brevets, censé protéger les #inventions techniques, a-t-il été dévoyé au point d’étouffer l’innovation et l’intérêt général ? Une enquête instructive.
Aux États-Unis, des femmes atteintes d’un cancer du sein ont mené une croisade juridique victorieuse contre Myriad Genetics. En brevetant deux gènes dont la mutation révèle une prédisposition au développement conjoint d’un cancer des ovaires, le laboratoire s’était assuré un monopole sur les tests de dépistage, mettant potentiellement en danger la vie de patientes, dans l’incapacité d’assumer le coût de l’examen. Alors que les lois sur les brevets ont été imaginées pour protéger les appareils et procédés techniques, comment expliquer que 20 % des gènes humains tombent aujourd’hui sous le coup de droits d’exclusivité d’#exploitation en Amérique ? Pour David Martin, spécialiste de la #propriété_intellectuelle, le tournant a eu lieu dans les années 1980 quand, dépassés par le Japon en nombre de brevets déposés, les États-Unis ont révisé leur législation. En supprimant l’obligation de prouver la mise en application d’une invention et en autorisant la brevetabilité de la recherche universitaire, ils ont ouvert la voie à une confiscation (provisoire) du savoir : une situation à l’origine d’un différend entre pays riches et pays en développement. Ces derniers militent, entre autres, pour un accès aux médicaments à des prix abordables. C’est le cas notamment de l’Inde qui, en plus de payer des licences, se voit contrainte de protéger ses #ressources_traditionnelles – du riz basmati aux postures de yoga –, pour éviter que d’autres ne les brevètent…
[80 minutes étouffantes - surtout pas gaspillées]
[ #ACTA ]
Open Source Seed Initiative: “Patents on naturally occurring biodiversity in plant breeding are an abuse of patent law,” the opposition statement read, “because instead of protecting inventions they become an instrument for the misappropriation of natural resources.”
Amazon dépose la photo sur fond blanc (v une info de @MathieuCoste)
27 minutes ago
"Amazon, qui vient de déposer la manière dont il prend les photos de produits, à savoir.... sur un fond blanc. Détaillant avec moult précisions les éléments qui constituent une prise de photo by Amazon, le géant du e-commerce a en effet souhaité protéger sa marque de fabrique en prohibant la copie parfaite de sa technique. Une technique qui repose certes sur de nombreuses conditions, mais qui, en termes de résultat, aboutit tout de même à... une prise de vue sur fond blanc. Autant dire que beaucoup de photographes pourraient être accusés de plagiat. Bien sûr, il paraît absurde d’imaginer un procès opposant deux parties qui débattent (...)
#Amazon #patents studio #photography on seamless white background:
So the next time you post one of your studio shots of a subject against a white background, don’t be surprised if you get a cease and desist letter from Amazon ordering you to stop using Amazon’s novel approach to studio lighting.
How “Candy Crush” is ruining the economy - Salon.com 24/01/14
On Tuesday, word began to spread that game developers were being asked to remove their Candy-named apps from the iTunes Store. Incredulity spread fast on Twitter, as it always does when a particularly egregious example of trademark overreach boils over. Most of the ire centered on the seeming absurdity of a business entity attempting to gain ownership of a word as commonly used as “candy” — two syllables that trace their etymological ancestry all the way back to Sanskrit!